Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr₹-1,091 Cr

What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES is ₹-799 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-799 Cr
Mar2023₹-797 Cr
Mar2022₹-532 Cr
Mar2021₹-35 Cr
Mar2020₹-1,091 Cr

How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹-797 Cr
Negative
Mar2022 ₹-532 Cr
Negative
Mar2021 ₹-35 Cr
Negative
Mar2020 ₹-1,091 Cr -

Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹181,418.8 Cr -0.7% 1.6% 50.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
MANKIND PHARMA ₹106,401.0 Cr 6.8% 8% 20.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-0.7%

1.6%

50.2%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses